Walgreens CEO Tim Wentworth at #JPM24 (Brian Benton Photography)
April 25, 2024 12:01 AM EDT
Cell/Gene Tx
Health Tech

Wal­greens will build out spe­cial­ty phar­ma­cy busi­ness, lean­ing in­to drug and ther­a­py ser­vices

Lydia Ramsey Pflanzer

Deputy Editor

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

Wal­greens said Thurs­day it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times